Modern Healthcare May 15, 2020
Despite minimal public disclosure and a leadership change two years into the highly anticipated healthcare joint venture, observers are still cautiously optimistic that Haven will help the industry progress.
Dr. Atul Gawande relinquished the chief executive role of the Amazon, JPMorgan Chase and Berkshire Hathaway venture for chairman of the board. Little is known about the endeavor, other than the founders’ description in early 2018 of an independent company “free from profit-making incentives and constraints” with the aim of improving employee satisfaction and reducing healthcare costs for their U.S. employees.
Reactions to the leadership change varied. It may indicate Haven is moving from the conceptual to implementation phase. Some are concerned that a lack of transparency means that little progress...
Today's Sponsors
Today's Sponsor